Clinical trial / 2011
A 12-week probiotic mixture of L. plantarum HEAL 9 and L. paracasei 8700:2 reduced common cold incidence and symptom days in healthy adults.
A randomised, double-blind, placebo-controlled study evaluated daily supplementation with 10^9 cfu of Lactobacillus plantarum HEAL 9 and Lactobacillus paracasei 8700:2 (N = 135) versus control (N = 137) over 12 weeks. The incidence of acquiring one or more common cold episodes decreased from 67% in controls to 55% in the probiotic group (p < 0.05). Days with common cold symptoms were significantly reduced from 8.6 days in controls to 6.2 days with probiotics (p < 0.05), and total symptom score dropped from 44.4 to 33.6, with a significant reduction in pharyngeal symptoms (p < 0.05). Additionally, the proliferation of B lymphocytes was significantly counteracted in the probiotic group (p < 0.05).
- Study type
- Randomised, parallel, double-blind placebo-controlled study
- Who was studied
- 272 healthy subjects
- What was measured
- Common cold episodes, days with symptoms, symptom severity, and cellular immune response
THE PAPER
Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections.
Berggren A, Lazou Ahrén I, Larsson N, Önning G. Eur J Nutr, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.